Wiadomości

E-Clinical Trial Technologies - Global Strategic Business Report 2026: Capitalize on 16.6% CAGR to US$32.8 Billion by 2032 as Oracle, Medidata, BioClinica and PAREXEL Disrupt Digital Trials

Yahoo

Company Logo Capitalize on decentralized trials, AI analytics and cloud eClinical platforms to cut costs, improve data quality, streamline compliance and boost patient engagement. Dublin, Nov. 16, 2026 (GLOBE NEWSWIRE) -- "e-Clinical Trial Technologies - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. Global e-Clinical Trial Technologies Market to Reach US$32.8 Billion by 2032 The global e-Clinical Trial Technologies market was valued at US$11.2 billion in 2025 and is projected to reach US$32.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 16.6%.

Przeczytaj pelny brief Veytics

Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.